Blueprint Medicines Files 8-K
| Field | Detail |
|---|---|
| Company | Blueprint Medicines Corp |
| Form Type | 8-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing
Related Tickers: BPMC
TL;DR
BPMC filed an 8-K on June 2, 2025, detailing a material agreement and other events.
AI Summary
On June 2, 2025, Blueprint Medicines Corporation (BPMC) filed an 8-K, reporting the entry into a material definitive agreement and other events. The filing also includes financial statements and exhibits. The company is incorporated in Delaware and headquartered in Cambridge, MA.
Why It Matters
This 8-K filing indicates significant corporate actions or agreements by Blueprint Medicines, which could impact its business operations and stock value.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting a material definitive agreement and other events, without immediate indication of significant financial distress or major strategic shifts.
Key Players & Entities
- Blueprint Medicines Corporation (company) — Registrant
- June 2, 2025 (date) — Date of Earliest Event Reported
- Delaware (jurisdiction) — State of Incorporation
- Cambridge, Massachusetts (location) — Principal Executive Offices
- 617-374-7580 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report the entry into a material definitive agreement and other events, as well as to include financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on June 2, 2025.
Where is Blueprint Medicines Corporation incorporated?
Blueprint Medicines Corporation is incorporated in Delaware.
What is the business address of Blueprint Medicines Corporation?
The business address of Blueprint Medicines Corporation is 45 Sidney Street, Cambridge, Massachusetts, 02139.
What is the registrant's telephone number?
The registrant's telephone number, including area code, is (617) 374-7580.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 2, 2025 regarding Blueprint Medicines Corp.